assay
≥99% (TLC)
form
powder
packaging
pkg of 1 × 1 mg (890812P-1MG), pkg of 1 × 5 mg (890812P-5MG)
manufacturer/tradename
Avanti Research™ - A Croda Brand
solubility
DMSO: soluble (1mg in 50uL of DMSO turns clear.)
application(s)
vaccine development
shipped in
dry ice
storage temp.
−20°C
SMILES string
CCCCCCCCCCCCNC(=O)C1OC(OC2CCC3(C)C(CCC4(C)C3CC=C3C5CC(C)(C)CCC5(CCC43C)C(=O)OC3OC(C)C(O)C(O)C3OC3OC(C)C(OC4OCC(O)C(O)C4O)C(OC4OC(CO)C(O)C(OC5OCC(O)C(O)C5O)C4O)C3O)C2(C)C=O)C(OC2OC(CO)C(O)C(O)C2O)C(OC2OC(C)C(O)C(O)C2O)C1O
General description
VSA-1 is a semisynthetic saponin adjuvant derived from the naturally occurring and readily accessible Momordica saponin, capable of stimulating antigen-specific humoral and cellular immune responses. Both VSA-1 and QS-21 significantly increased the titers of IgG and opsonic antibodies against seven selected serotypes, including serotypes 3, 14, and 19A, which are associated with most PCV13 breakthrough infections.
Application
Vaccine development
Packaging
5 mL Amber Glass Screw Cap Vial (890812P-1MG); 5 mL Amber Glass Screw Cap Vial (890812P-5MG)
Legal Information
Avanti Research is a trademark of Avanti Polar Lipids, LLC
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable